Infinium Pharmachem Limited (NSE:INFINIUM)

Infinium Pharmachem Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	308.81	29.98	120.33	38.28	59.79	54.51
Short-Term Investments	-	267.82	228.07	80.83	-	-
Cash & Short-Term Investments	308.81	297.81	348.4	119.11	59.79	54.51
Cash Growth	107.47%	-14.52%	192.49%	99.20%	9.69%	340.65%
Accounts Receivable	485.04	314.62	337.47	204.53	154.32	153.92
Other Receivables	-	23.73	44.56	20.96	31.58	31.2
Receivables	544.55	338.35	382.02	225.48	185.9	185.11
Inventory	425.02	419.19	632.6	270.08	231.03	179.11
Prepaid Expenses	-	8.16	4.54	-	-	-
Other Current Assets	45.33	36.48	31.6	35.43	36.41	18.1
Total Current Assets	1,324	1,100	1,399	650.11	513.13	436.84
Property, Plant & Equipment	321.94	282.33	216.09	196.5	188.06	126.79
Long-Term Investments	290.25	290.25	290.25	-	-	-
Goodwill	33.95	33.95	33.95	-	-	-
Long-Term Deferred Tax Assets	2.13	2.41	1.49	0.17	0.52	0.67
Other Long-Term Assets	16.62	40.44	42.91	7.74	4.41	25.69
Total Assets	1,995	1,749	1,984	854.53	706.12	590

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	213.97	40.73	123.86	45.13	68.28	118.17
Accrued Expenses	-	27.8	15.81	5.41	4.12	12.6
Short-Term Debt	-	115.98	348.52	33.53	155.63	86.71
Current Portion of Long-Term Debt	-	36.19	69.98	0.85	36.16	2.26
Current Portion of Leases	-	0.69	-	-	-	-
Current Income Taxes Payable	28.08	36.4	35.72	36.71	30.91	19.39
Other Current Liabilities	138.99	28.96	42.04	52.5	72.6	75.41
Total Current Liabilities	381.04	286.74	635.91	174.13	367.69	314.54
Long-Term Debt	-	-	-	-	100.61	136.24
Long-Term Leases	-	1.69	-	-	-	-
Other Long-Term Liabilities	118.92	76.39	99.97	78.06	-	-
Total Liabilities	499.96	364.81	735.88	252.2	468.3	450.78

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	155.83	155.83	155.83	139.16	50.83	10.17
Additional Paid-In Capital	-	568.23	568.23	161.28	-	7.66
Retained Earnings	-	490.83	369.33	287.88	174.85	112.96
Comprehensive Income & Other	1,150	-4.42	1.25	-0.52	-0.07	0.24
Total Common Equity	1,306	1,210	1,095	587.79	225.61	131.02
Minority Interest	188.61	174.08	153.33	14.54	12.21	8.19
Shareholders' Equity	1,495	1,385	1,248	602.33	237.82	139.22
Total Liabilities & Equity	1,995	1,749	1,984	854.53	706.12	590

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	-	154.54	418.49	34.38	292.4	225.21
Net Cash (Debt)	308.81	143.27	-70.09	84.73	-232.6	-170.69
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	19.83	9.19	-4.82	7.95	-22.88	-16.79
Filing Date Shares Outstanding	15.58	15.58	15.58	13.92	13.92	10.17
Total Common Shares Outstanding	15.58	15.58	15.58	13.92	10.17	10.17
Working Capital	942.67	813.25	763.26	475.98	145.44	122.3
Book Value Per Share	83.86	77.68	70.25	42.24	22.19	12.89
Tangible Book Value	1,272	1,177	1,061	587.79	225.61	131.02
Tangible Book Value Per Share	81.68	75.50	68.07	42.24	22.19	12.89
Land	-	8.47	7.98	-	7.98	7.98
Buildings	-	72.63	71.07	-	51.3	12.84
Machinery	-	216.46	197.76	-	149.32	56.52
Construction In Progress	-	81.58	8.47	0.15	-	84.8

Data Source: S&P Global Market Intelligence Last updated: Aug 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 11, 2026

Data Sources Report a data error